ILLUMINA SINGAPORE

Last Updated: 31 Jan 2025

At Illumina, our mission is to accelerate the discovery, development, and delivery of innovative genomic solutions for disease research, drug development, and molecular diagnostics. Our cutting-edge technologies and assays enable scientists and clinicians to analyze genetic variation and function at unprecedented speed and scale, paving the way for personalized medicine. We prioritize collaboration, rapid solution delivery, and customer satisfaction, providing industry-leading support and service to our global customer base.

Country of registration	Singapore
Registration number	200310311N
Local SIC	32501: Manufacture of medical research and clinical diagnostic instruments and supplies (eg reagents)
Incorporation date	14 Oct 2003
Company age	22 years 5 months
Official entity type	Private Limited Company
No. of officers	32

Contact

Address:

29 WOODLANDS INDUSTRIAL PARK E1, #02-13/18, NORTHTECH, Singapore 757716

Phone number:

Access Key Decision Makers

This is the legal entity page of ILLUMINA SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

ILLUMINA
United States of America
View More
genomics
personalized_medicine
disease_research
drug_development
molecular_diagnostics
cutting_edge_technology
collaboration
rapid_solution_delivery
customer_satisfaction
Manufacturing
At Illumina, our mission is to accelerate the discovery, development, and delivery of innovative genomic solutions for disease research, drug development, and molecular diagnostics. Our cutting-edge technologies and assays enable scientists and clinicians to analyze genetic variation and function at unprecedented speed and scale, paving the way for personalized medicine. We prioritize collaboration, rapid solution delivery, and customer satisfaction, providing industry-leading support and service to our global customer base.

This is the legal entity page of ILLUMINA SINGAPORE. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Fiscal/Budgeting Period	November - January
Auditor	ERNST & YOUNG LLP
Revenue	1.1b - 2.5b
Financial period end date	2 Jan 2022
Share Capital - Ordinary shares	SGD 146,762,945

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of ILLUMINA SINGAPORE?
Where is ILLUMINA SINGAPORE's headquarter?
What is ILLUMINA SINGAPORE's contact number?
What ILLUMINA SINGAPORE's spending power?
Does ILLUMINA SINGAPORE have a presence in the domain it operates in?